Publications by authors named "U H Jo"

DNA-protein cross-links (DPCs) are among the most detrimental genomic lesions. They are ubiquitously produced by formaldehyde (FA), and failure to repair FA-induced DPCs blocks chromatin-based processes, leading to neurodegeneration and cancer. The type, structure, and repair of FA-induced DPCs remain largely unknown.

View Article and Find Full Text PDF

Transitional cell metaplasia (TCM) resembling benign urothelium is commonly seen around the distal fallopian tube and/or neighboring mesothelial surface; however, its histogenesis remains largely unknown. We observed the emergence of a cytokeratin (CK) 17-positive reserve cell layer in early TCM foci beneath the tubal epithelium, leading us to hypothesize that TCM could be derived from reserve cells. To elucidate the histogenetic process of TCM, we analyzed the histomorphologic features and immunoprofiles for CK17, CK5/6, p63, GATA-3, estrogen receptor (ER), and androgen receptor (AR) in TCM foci arising in the tubal epithelium (31 foci) and pelvic mesothelium (35 foci).

View Article and Find Full Text PDF

An adenomatoid tumor (AT) is a benign lesion, which is commonly located in the genital tract of both sexes. We present a case of a 66-yr-old woman with the unusual characteristics of an AT mimicking peritoneal carcinomatosis. The tumor was detected incidentally by ultrasound examination, and an ensuing imaging study raised suspicion of ovarian cancer with peritoneal carcinomatosis.

View Article and Find Full Text PDF
Article Synopsis
  • A case report details a 27-year-old woman with tuberous sclerosis who experienced spontaneous uterine rupture, leading to emergency surgery where they discovered damage consistent with lymphangioleiomyomatosis.
  • The case emphasizes the need for early diagnosis and monitoring in women of reproductive age due to risks associated with estrogen, highlighting the importance of thorough evaluations in complicated medical situations.
View Article and Find Full Text PDF
Article Synopsis
  • PD-L1 expression serves as a crucial biomarker in predicting how patients with head and neck squamous cell carcinoma might respond to immune checkpoint inhibitors, making it important to evaluate different testing methods.
  • A study conducted at Asan Medical Center evaluated PD-L1 expression in 156 cases using various standardized assays and a laboratory-developed test, revealing good to excellent agreement among the methods.
  • The results highlighted that PD-L1 expression significantly varies with tumor location and suggests that the different assays could potentially be used interchangeably for assessing PD-L1 in head and neck cancers.
View Article and Find Full Text PDF